Literature DB >> 2144167

Adjuvant therapy for colon and rectal cancer. NIH Consensus Development Conference.

U Metzger1.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2144167     DOI： 10.1016/0277-5379(90)90136-h

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  5 in total

1.  Improving survival after large bowel cancer.

Authors:  S Whitaker
Journal:  BMJ       Date:  1991-10-12

2.  Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study.

Authors:  Ya-Hsu Yang; Jen-Kou Lin; Wei-Shone Chen; Tzu-Chen Lin; Shung-Haur Yang; Jeng-Kai Jiang; Shih-Ching Chang; Yuan-Tzu Lan; Chun-Chi Lin; Chueh-Chuan Yen; Cheng-Hwai Tzeng; Wei-Shu Wang; Huey-Ling Chiang; Chung-Jen Teng; Hao-Wei Teng
Journal:  Support Care Cancer       Date:  2011-08-04       Impact factor: 3.603

3.  Racial/Ethnic and Socioeconomic Differences in Colorectal and Breast Cancer Treatment Quality: The Role of Physician-level Variations in Care.

Authors:  Ioana Popescu; Deborah Schrag; Alfonso Ang; Mitchell Wong
Journal:  Med Care       Date:  2016-08       Impact factor: 2.983

4.  [Is adjuvant chemotherapy of colon cancers (Dukes C; TxN+) regarded as standard today?].

Authors:  E Farthmann; C Herfarth; U Laffer; F Harder; P M Schlag; H Wilke
Journal:  Langenbecks Arch Chir       Date:  1993

Review 5.  Adjuvant chemotherapy for colon cancer.

Authors:  S K Kumar; R M Goldberg
Journal:  Curr Oncol Rep       Date:  2001-03       Impact factor: 5.945
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.